Jefferies Financial Group Inc. Axsome Therapeutics, Inc. Transaction History
Jefferies Financial Group Inc.
- $11 Billion
- Q2 2025
A detailed history of Jefferies Financial Group Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 2,500 shares of AXSM stock, worth $332,875. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500Holding current value
$332,875% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding AXSM
# of Institutions
413Shares Held
37.4MCall Options Held
710KPut Options Held
541K-
Vanguard Group Inc Valley Forge, PA3.95MShares$525 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$439 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$225 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$202 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$151 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.71B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...